| Primary |
| Drug Use For Unknown Indication |
25.1% |
| Product Used For Unknown Indication |
22.1% |
| Bronchitis |
10.9% |
| Sinusitis |
8.6% |
| Urinary Tract Infection |
5.6% |
| Bacterial Infection |
2.6% |
| Cough |
2.6% |
| Upper Respiratory Tract Infection |
2.6% |
| Pharyngitis |
2.3% |
| Ear Infection |
2.0% |
| Haemorrhoids |
2.0% |
| Hypertension |
2.0% |
| Pericoronitis |
2.0% |
| Pneumonia |
2.0% |
| Tonsillitis |
1.7% |
| Hiv Infection |
1.3% |
| Premedication |
1.3% |
| Pyrexia |
1.3% |
| Analgesic Intervention Supportive Therapy |
1.0% |
| Bronchopneumonia |
1.0% |
|
| Vomiting |
19.8% |
| Urticaria |
13.2% |
| Product Quality Issue |
8.8% |
| Pruritus |
4.4% |
| Pyrexia |
4.4% |
| Rash Generalised |
4.4% |
| Swelling Face |
4.4% |
| Tachycardia |
4.4% |
| Thrombocytopenia |
4.4% |
| Dyspnoea |
3.3% |
| Rash |
3.3% |
| Rectal Haemorrhage |
3.3% |
| Somnolence |
3.3% |
| Weight Decreased |
3.3% |
| Wheezing |
3.3% |
| White Blood Cell Count Increased |
3.3% |
| Abortion Spontaneous |
2.2% |
| Death |
2.2% |
| Dermatitis Allergic |
2.2% |
| Diarrhoea |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
14.4% |
| Hypertension |
11.6% |
| Anaesthesia |
8.8% |
| Drug Use For Unknown Indication |
8.8% |
| Diarrhoea |
7.9% |
| Sinusitis |
7.4% |
| Cough |
3.7% |
| Renal Transplant |
3.7% |
| Urinary Tract Infection |
3.7% |
| Angina Pectoris |
3.2% |
| Diverticulitis |
3.2% |
| Hypercholesterolaemia |
3.2% |
| Insomnia |
3.2% |
| Prophylaxis |
3.2% |
| Bacterial Infection |
2.8% |
| Anaemia |
2.3% |
| Bronchitis |
2.3% |
| Candidiasis |
2.3% |
| Cardiovascular Event Prophylaxis |
2.3% |
| Dyspepsia |
1.9% |
|
| Colitis Ischaemic |
17.4% |
| Thrombocytopenia |
17.4% |
| Hepatitis Cholestatic |
8.7% |
| Vision Blurred |
8.7% |
| Gastroenteritis Clostridial |
6.5% |
| Anaphylactic Shock |
4.3% |
| Pyrexia |
4.3% |
| Skin Disorder |
4.3% |
| Weight Decreased |
4.3% |
| Cytolytic Hepatitis |
2.2% |
| Hypertension |
2.2% |
| Hypokalaemia |
2.2% |
| Ill-defined Disorder |
2.2% |
| Infection Parasitic |
2.2% |
| Oxygen Saturation Immeasurable |
2.2% |
| Petechiae |
2.2% |
| Pneumonia |
2.2% |
| Rash |
2.2% |
| Retching |
2.2% |
| Skin Exfoliation |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
16.1% |
| Product Used For Unknown Indication |
11.6% |
| Prophylaxis |
8.4% |
| Nausea |
6.3% |
| Pain |
4.8% |
| Constipation |
4.5% |
| Diarrhoea |
4.5% |
| Bronchitis |
4.2% |
| Odynophagia |
4.2% |
| Hypertension |
3.9% |
| Drug Exposure During Pregnancy |
3.6% |
| Dyspepsia |
3.6% |
| Hiv Infection |
3.6% |
| Stomatitis |
3.6% |
| Convulsion |
3.3% |
| Antibiotic Therapy |
3.0% |
| Metastatic Gastric Cancer |
3.0% |
| Prophylaxis Of Nausea And Vomiting |
3.0% |
| Pyrexia |
2.7% |
| Anaemia |
2.4% |
|
| No Adverse Event |
15.2% |
| Premature Rupture Of Membranes |
8.7% |
| Pyrexia |
8.7% |
| Diarrhoea |
6.5% |
| Cardiac Failure |
4.3% |
| Death |
4.3% |
| Death Neonatal |
4.3% |
| Dehydration |
4.3% |
| Hydrothorax |
4.3% |
| Large Intestinal Obstruction |
4.3% |
| Liver Function Test Abnormal |
4.3% |
| Nausea |
4.3% |
| Oedema |
4.3% |
| Renal Failure Acute |
4.3% |
| Ventricular Arrhythmia |
4.3% |
| Vomiting |
4.3% |
| Alanine Aminotransferase Increased |
2.2% |
| Deep Vein Thrombosis |
2.2% |
| Dermatitis Exfoliative |
2.2% |
| Dyspnoea |
2.2% |
|
